The mechanism of p53-mediated apoptosis remains poorly understood. Current evidence suggests that p53 induces cell death by separate transcription-dependent and -independent pathways. Mitochondrial involvement is critical for most forms of cell death. Data from the investigator's laboratory suggests that in cells with an intact p53- mediated apoptotic pathway, p53 protein is physically present within the mitochondria in a specific low-abundance protein complex with mt-hsp 70. Mt-hsp70 likely mediates mitochondrial import and refolding of p53. This apparent organellar location strongly argues for a direct transcription- independent regulatory role of p53 in the mitochondrial phase of apoptosis. In contrast, neuroblastoma cells which are resistant to apoptosis under the conditions tested, appear to contain abnormally high (deregulated) levels of mitochondrial p53/mt-hsp70 complexes, associated with covalent modification of p53. This suggests an altered function of p53 which may result in an anti-apoptotic phenotype at the mitochondrial level in this tumor. Biochemical and genetic experiments addressing the functional significance of p53's presence within mitochondria under physiological conditions are the core of this proposal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA060664-06
Application #
2752155
Study Section
Pathology B Study Section (PTHB)
Program Officer
Gallahan, Daniel L
Project Start
1993-09-15
Project End
2002-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Pathology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Yallowitz, A R; Alexandrova, E M; Talos, F et al. (2014) p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis. Cell Death Differ 21:645-54
Hanel, W; Marchenko, N; Xu, S et al. (2013) Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ 20:898-909
Hanel, Walter; Moll, Ute M (2012) Links between mutant p53 and genomic instability. J Cell Biochem 113:433-9
Vaseva, Angelina V; Marchenko, Natalie D; Ji, Kyungmin et al. (2012) p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149:1536-48
Li, D; Marchenko, N D; Moll, U M (2011) SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ 18:1904-13
Hagn, Franz; Klein, Christian; Demmer, Oliver et al. (2010) BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J Biol Chem 285:3439-50
Marchenko, N D; Hanel, W; Li, D et al. (2010) Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ 17:255-67
Vaseva, Angelina V; Moll, Ute M (2009) The mitochondrial p53 pathway. Biochim Biophys Acta 1787:414-20
Vaseva, Angelina V; Marchenko, Natalia D; Moll, Ute M (2009) The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle 8:1711-9
Becker, Kerstin; Marchenko, Natalia D; Palacios, Gustavo et al. (2008) A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle 7:1205-13

Showing the most recent 10 out of 16 publications